AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi, GlaxoSmithKline Pakistan. NC (GLAXO), a significant entity in the pharmaceutical industry since 1953, maintained consistent market performance in 2023. The company’s stock traded at a high rate of Rs. 83.70 and a low rate of Rs. 84.16. With a paid-up capital of Rs. 3,184.67 million, GlaxoSmithKline Pakistan reported an EPS of Rs. 68 for the year. No distributions were announced for 2022 or 2023.
Check Also
Dar Discusses Regional Developments with Foreign Ministers of Singapore and Indonesia
Islamabad: Deputy Prime Minister and Foreign Minister Ishaq Dar interacted with Foreign Minister of Singapore, Dr. Vivian Balakrishnan, and Foreign Minister of Indonesia, Sugiono, ahead of the plenary session of the ASEAN Regional Forum Ministerial Me...